Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus
Berkowitz SA, Sussman JB, Jonas DE, Basu S
Journal of the American College of Cardiology. 2018;72(11):1214
Leggi
Breaking news
Primary Prevention with Statins for Older Adults
Ryan A, Heath S, Cook P
BMJ 2018;362:k3695
Leggi
Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study
Nam GE, Kim SM, Han K, et al.
PLoS Med. Pub. online August 21, 2018
Leggi
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
Perkovic V, de Zeeuw D, Mahaffey KW, et al.
Lancet Diabetes Endocrinol 2018;6(9):691-704
Leggi
Health service utilization and related costs attributable to diabetes
O’Neill KN, McHugh SM, Tracey ML, et al.
Diabet Med. Pub. online 28 August 2018
Leggi
Semaglutide and GLP-1 analogues as weight-loss agents
Kluger AY, McCullough PA
Lancet 2018;392(10148):615-6
Leggi
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double blind, placebo and active controlled, dose-ranging, phase 2 trial
O’Neil PM, Birkenfeld AL, McGowan B, et al.
Lancet 2018;392(10148):637-49
Leggi
Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records
Feng QP, Wei WQ, Chung CP, et al.
PLoS Med. Pub. online August 28, 2018
Leggi
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy.A Randomized Clinical Trial
Gross JG, Glassman AR, Liu D, et al.
JAMA Ophthalmol. Pub. online July 24, 2018
Leggi
Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program
Billings LK, Parkin CG, Price D
Diabetes Technol Ther. Pub. online 25 July 2018
Leggi